HLA Typing Market By Product (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), By Application (Diagnostic Applications and Research Applications), By End-Users (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes), Geography (North America, Europe, APAC, RoW) Forecast up to 2026

    Published: Jul 2020Report ID: HTHCM0121108 Pages
    108
    Pages
    76
    Tables
    46
    Figures
    10
    Countries

    Report Summary

    HLA Typing Market By Product (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), By Application (Diagnostic Applications and Research Applications), By End-Users (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes), Geography (North America, Europe, APAC, RoW) Forecast up to 2026

    HLA (Human Leukocyte Antigen) Typing is a kind of genetic test conducted to check individual differences in an immune system of the person. This test is important to identify whether a person is capable to safely donate bone marrow, cord blood, or any other organ to any person who is in need of a transplant. There is a rapid growth in the demand for transplant diagnostic products due to factors such as public and private increased funding in target research activities. Majorly the increase in certain diseases such as blood cancers, genetic blood disorders where stem cell transplantation is required, this situation is expected to drive the HLA Typing market. However, the limited reimbursements for target procedures are a restrain for this market. The HLA typing market is expected to reach USD 990.12 million by 2026 from USD 659.75 million in 2020, at a CAGR of ~7.0%.

    Research Methodology:

    The HLA typing market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

    The scope of the HLA Typing market is defined in the segmentation includes:

    By Product and Service:

    Reagents & Consumables

    Instruments

    Software & Services

    By Technology:

    Molecular Assay Technologies

    PCR-Based Molecular Assays

    Sequence-specific oligonucleotide-PCR

    Sequence-specific primer-PCR

    Real-time PCR

    Other PCR-based molecular assays

    Sequencing-Based Molecular Assays

    Sanger sequencing

    Next-generation sequencing

    Other sequencing-based molecular assays

    Sequencing-Based Molecular Assay

    Non-Molecular Assay Technologies

    By Application:

    Diagnostic Applications

    Antibody Screening

    Chimerism Monitoring

    Other Applications

    Research Applications

    By End User:

    Independent Reference Laboratories

    Hospitals & Transplant Centers

    Research Laboratories & Academic Institutes

    By Region:

    North America

    Europe

    APAC

    Rest of World

    The global HLA (Human Leukocyte Antigen) Typing market is segmented based on end-user. The segment of independent reference laboratories accounted for the largest share in the market due to the increased demand for organ transplant procedures, improved and automated diagnostic laboratories, increasing research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories.

    The global HLA Typing market is segmented based on end-user. The independent reference laboratories segment, which accounted for the largest share in the market with increased demand for organ transplant procedures, improved and automated diagnostic laboratories, increasing research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories.

    Further, HLA Typing market segmentation based on product and service includes Reagents & Consumables, Instruments, software & services. In this market segment, reagent and consumables play a major role in the market growth because of the early patient profiling during organ transplantation.

    Based on technology, the market is divided into molecular assay technologies and non- molecular technologies. By analysis, the molecular assay technology has the majority of the demand in the HLA typing. The molecular assay technology consumes less time as compared to other technology and gives effective results that support market growth.

    Moreover, the HLA Typing market based on region is segmented into four regions, including North America, Europe, Asia Pacific, and RoW. Further, the North America region is accounted for the largest share of the transplant market due to the well-developed market for medical devices, highly improvised healthcare system, a rapid increase in the adoption of the innovative transplant diagnostic technologies.

    Globally, the HLA Typing market is growing at a CAGR of ~7.0% during the forecast period of 2020-2026. The factors which are majorly driving this market are innovative technologies in the transplant procedures and increasing transplant procedures, a large number of research and development activities in this field of HLA Typing. Molecular tests include high expenses for the HLA typing test, which is standing as a constraint in this market.

    Globally HLA Typing market is playing a major role in the transplant diagnostic field, giving an accurate analysis of the person’s immune system for further transplantation process. An increase in the adoption of cross-matching and chimerism testing during post and pre-transplantation gives the opportunity in the market. However, due to the number of donors compared to donor accepters are very less, the market is facing a major challenge in the growth of the market.

    Some of the prominent players in the HLA Typing Market are Thermo Fisher Scientific, Inc., Omixon, CareDx, Inc, QIAGEN N.V., Luminex, Biofortuna, Illumina, Bio-Rad Laboratories, Inc., Takara Bio, TBG Diagnostics Ltd., and F. Hoffman-La Roche Ltd.

    Moreover, the awareness about organ donation and transplantation across the developing countries and emerging technologies are supporting the HLA Typing Market growth globally. This report will enable the market players to understand the key market trends, market dynamics, and critical needs of the end-users. The qualitative and quantitative analysis covered in the study would enhance the user utility of the report.

    The competitive analysis of the major players enables users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions and joint ventures of the key players

    This report also provides the portfolio analysis, capability analysis of the leading players

    The report will also help the research organization of HLA Typing market to support their development activities

    Quantitative analysis of the market enables users to understand the actual facts of the market across four major regions

    Key Questions Answered in This Report

    • What are the key market trends and growth drivers?
    • Who are the major players and what are their market strategies?
    • What is the market size and forecast for the coming years?
    • What are the regional market dynamics and opportunities?

    Select License Type

    $4,000
    $4,500
    $5,500
    Category:Healthcare
    Industry:Healthcare
    Published:Jul 2020
    Pages:108